Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
OTC Drug And Dietary Supplement Global Market Opportunities And Strategies To 2033

OTC Drug And Dietary Supplement Market 2024 – By Product (Active Hemostats, Passive Hemostats, Combination Hemostats, Other Products), By Formulation (Matrix And Gel Hemostats, Sheet And Pad Hemostats, Sponge Hemostats, Powder Hemostats, Other Formulations), By Application (Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, Other Applications), And By Region, Opportunities And Strategies – Global Forecast To 2032

OTC Drug And Dietary Supplement Global Market Opportunities And Strategies To 2033

Starting Price : $5000.00 $3500.00 | Pages : 323 | Published : October 2024 | | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

OTC Drug And Dietary Supplement Market Definition

The OTC (over the counter) drug and dietary supplement market encompasses products that consumers can purchase without a prescription for self-care and health maintenance.

The OTC drugs and dietary supplement market consists of sales, by entities (organizations, sole traders and partnerships), of OTC drugs and dietary supplement. OTC drugs are used to treat various minor health issues, while dietary supplements provide nutritional support, such as vitamins, minerals, and other substances. These products are widely utilized by individuals seeking to manage minor ailments or boost their overall health without the need for medical consultation. They play a critical role in public health by offering accessible and often more affordable options for symptom relief and wellness.

Book your 30 minutes free consultation with our research experts

Contact Us

OTC Drug And Dietary Supplement Market Size

The global OTC drug and dietary supplement market reached a value of nearly $310,965.5 million in 2023, having grown at a compound annual growth rate (CAGR) of 6.8% since 2018. The market is expected to grow from $310,965.5 million in 2023 to $438,256.2 million in 2028 at a rate of 7.1%. The market is then expected to grow at a CAGR of 7.6% from 2028 and reach $632,108.7 million in 2033.

Growth in the historic period resulted from rise in pharma research and development (R&D) expenditure, rising healthcare expenditure, growing fitness industry and growing use of telemedicine services. Factors that negatively affected growth in the historic period were lack of awareness.

Going forward, increase in health consciousness, increasing demand for dietary supplements, rising government initiatives, increasing aging population worldwide and expansion of the e-commerce industry will drive the growth. Factor that could hinder the growth of the OTC drug and dietary supplement market in the future include side effects and safety concerns.  

OTC Drug And Dietary Supplement Market Drivers

The key drivers of the OTC drug and dietary supplement market include:

Increase In Health Consciousness

The rising health consciousness is expected to drive the growth of the OTC drug and dietary supplement market. Health consciousness refers to the awareness and concern individuals have regarding their health and well-being. It involves being mindful of one's lifestyle choices, including diet, exercise, sleep and stress management. Health consciousness influences dietary supplement testing services by driving demand for quality assurance, transparency, safety and efficacy, ultimately contributing to the promotion of consumer health and well-being. For instance, in 2023, according to an online survey conducted by the International Food Information Council, a US-based nonprofit organization, among 1,022 Americans aged between 18 to 80, 52% of Americans followed a diet or eating pattern in the 2022, a significant increase from the past few years (39% in 2021), which increased compared to previous years and is expected to rise in the coming years. Therefore, rising health consciousness is expected to drive the growth of the OTC drug and dietary supplement market.

OTC Drug And Dietary Supplement Market Restraints

The key restraints on the OTC drug and dietary supplement market include:

Side Effects And Safety Concerns

Side effects and safety concerns are expected to restrict the growth of the OTC drug and dietary supplement market going forward. Safety concerns and reported side effects have the potential to diminish consumer confidence in OTC products and brands. Consumers may hesitate to use specific supplements or medications if they view them as potentially unsafe or ineffective, impacting their willingness to purchase and use these products. This erosion of trust can significantly affect market acceptance and consumer adoption of OTC offerings. For instance, in November 2023, according to the American Association of Retired Persons (AARP), a US-based nonpartisan, nonprofit organization, it is estimated that adverse reactions from over the counter (OTC) medications result in approximately 178,000 hospitalizations annually in the United States. Adults aged 65 and older are particularly susceptible to these harmful effects.  Therefore, the side effects and safety concerns may hinder the growth of the OTC drug and dietary supplement market.

OTC Drug And Dietary Supplement Market Trends

Major trends shaping the OTC drug and dietary supplement market include:

Expansion Of Production Capabilities In Dietary Supplements And OTC Drugs

Major companies operating in the OTC drug and dietary supplement market are focusing on expansion of production capabilities in dietary supplements and over-the-counter drugs which positions the company to capitalize on market opportunities and respond swiftly to consumer needs. For instance, in January 2024, Hi-Tech Pharmaceuticals, a US-based manufacturer and supplier of dietary supplements and over the counter (OTC) drug products, expanded its production capabilities to meet the increasing demand for dietary supplements and over-the-counter (OTC) drugs. The company has added four additional Stokes 328 tablet presses to its facilities. Two of these presses will be dedicated to producing its innovative weight management product, SLIMAGLUTIDE®, while the other two will be used for its Ameripharm brand of OTC products and to partner with retailers in manufacturing generic versions of popular cough and mucus-fighting medications, such as Mucinex. This investment in new equipment will significantly enhance Hi-Tech's capacity to manufacture large tablets for its Cyclosome technology and Guaifenesin OTC drug products.

New Over-The-Counter Option For Opioid Overdose Reversal

Companies operating in the OTC drug and dietary supplement market are deploying new over-the-counter options for opioid overdose reversal. It facilitates access to a critical life-saving intervention, potentially lowering fatalities in emergency scenarios where immediate medical help may be limited or unavailable. For instance, in April 2024, Amneal Pharmaceuticals, Inc., a US-based generics and specialty pharmaceutical company, has announced the U.S. FDA approval and availability of its over-the-counter (OTC) Naloxone Hydrochloride (Naloxone HCI) Nasal Spray, USP, 4mg. This product is a generic equivalent to OTC NARCAN® HCI Nasal Spray and is intended for the emergency treatment of opioid overdoses, including those involving heroin, fentanyl and prescription opioids. Amneal's Naloxone HCI Nasal Spray is formulated to quickly reverse the life-threatening effects of an opioid overdose by binding to opioid receptors and restoring normal respiration within two to three minutes in individuals whose breathing has significantly slowed or stopped.

Opportunities And Recommendations In The OTC Drug And Dietary Supplement Market

Opportunities – The top opportunities in the OTC drug and dietary supplement market segmented by category will arise in the vitamin and dietary supplements segment, which will gain $57,733.0 million of global annual sales by 2028. The top opportunities in the OTC drug and dietary supplement market segmented by dosage form will arise in the tablets segment, which will gain $46,768.8 million of global annual sales by 2028. The top opportunities in the OTC drug and dietary supplement market segmented by distribution channel will arise in the pharmacies segment, which will gain $60,260.0 million of global annual sales by 2028. The OTC drug and dietary supplement market size will gain the most in the USA at $32,639.6 million.

Recommendations- To take advantage of the opportunities, The Business Research Company recommends the OTC drug and dietary supplement companies to focus on production expansion for market leadership, focus on expanding access to opioid overdose reversal solutions, focus on developing natural herb-based supplements for nursing mothers, focus on expanding OTC drug lines for pain and allergy relief, focus on innovating with OTC oral contraceptives, focus on vitamin and dietary supplements segment, focus on online pharmacies, focus on expanding presence in emerging markets, focus on competitive pricing strategies, embrace digital marketing channels, educate consumers through content marketing and focus on targeting aging population effectively.

OTC Drug And Dietary Supplement Market Segmentation

The OTC drug and dietary supplement market is segmented by category, by dosage form and by distribution channel.

By Category –
The OTC drug and dietary supplement market is segmented by category into:
    • a) Vitamin And Dietary Supplements
    • b) Cough And Cold Dosage Forms
    • c) Analgesics
    • d) Gastrointestinal Dosage Forms
    • e) Skin
    • f) Other Categories
The vitamin and dietary supplement market was the largest segment of the OTC drug and dietary supplement market segmented by category, accounting for 38.5% or $119,718.5 million of the total in 2023. Going forward, the vitamin and dietary supplement segment is expected to be the fastest growing segment in the OTC drug and dietary supplement market segmented by category, at a CAGR of 8.2% during 2023-2028.

By Dosage Form –
The OTC drug and dietary supplement market is segmented by dosage form into:
    • a) Tablets
    • b) Hard Capsules
    • c) Powders
    • d) Ointments
    • e) Soft Capsules
    • f) Liquids
    • g) Other Dosage Forms
The tablets market was the largest segment of the OTC drug and dietary supplement market segmented by dosage form, accounting for 33.2% or $103,265.5 million of the total in 2023. Going forward, the soft capsules segment is expected to be the fastest growing segment in the OTC drug and dietary supplement market segmented by dosage form, at a CAGR of 8.3% during 2023-2028.

By Distribution Channel –
The OTC drug and dietary supplement market is segmented by distribution channel into:
    • a) Pharmacies
    • b) Grocery Stores
    • c) Vitamin And Health Food Stores
    • d) Online Pharmacies
The pharmacies market was the largest segment of the OTC drug and dietary supplement market segmented by distribution channel, accounting for pharmacies % or $144,130.3 million of the total in 2023. Going forward, the online pharmacies segment is expected to be the fastest growing segment in the OTC drug and dietary supplement market segmented by distribution channel, at a CAGR of 8.5% during 2023-2028.

By Geography - The OTC drug and dietary supplement market is segmented by geography into:
      o Asia Pacific
      • • China
      • • India
      • • Japan
      • • Australia
      • • Indonesia
      • • South Korea
      o North America
      • • USA
      • • Canada
      o South America
      • • Brazil
      o Western Europe
      • • France
      • • Germany
      • • UK
      • • Italy
      • • Spain
      o Eastern Europe
      • • Russia
      o Middle East
      o Africa
North America was the largest region in the OTC drug and dietary supplement market, accounting for 42.7% or $132,848.0 million of the total in 2023. It was followed by Asia-Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the OTC drug and dietary supplement market will be Asia-Pacific and Africa where growth will be at CAGRs of 9.9% and 9.3% respectively. These will be followed by the Middle East and South America where the markets are expected to grow at CAGRs of 8.7% and 7.9% respectively.

OTC Drug And Dietary Supplement Market Competitive Landscape

Major Competitors are:

  • Nestlé S.A.
  • Procter & Gamble Co.
  • Haleon plc
  • Abbott Laboratories
  • Sanofi S.A.

    • Other Competitors Include:

  • Reckitt Benckiser Group plc
  • Bayer AG
  • Church & Dwight Co. Inc.
  • Nature’s Bounty Co.
  • Perrigo Company plc
  • PT Darya-Varia Laboratoria Tbk
  • Citra Nusa Insan Cemerlang PT
  • Sido Muncul
  • Tempo Scan Pacific Tbk PT
  • Ajinomoto Co. Inc
  • Otsuka Pharmaceutical Co., Ltd.
  • KOBAYASHI Pharmaceutical Co.,Ltd.
  • Blackmores Limited
  • Fonterra Co-operative Group Limited
  • Dong-A Pharmaceutical Co., Ltd.
  • Kolmar Korea
  • Il Yang Pharmaceutical
  • Pulmuone Health & Living Co Ltd
  • Emcure Pharmaceuticals Limited
  • GSK plc
  • BASF SE
  • Glanbia plc
  • Perrigo Company plc
  • ARKOPHARMA Laboratories Company Limited
  • Laboratorios Rubió S.A.
  • Fisiopharma S.r.l.
  • Juvamine
  • Solgar Science
  • Oenobiol
  • Naturactive
  • Puressentiel
  • Danone S.A.
  • AstraZeneca plc
  • LEO Pharma A/S
  • Novartis AG
  • Omega Pharma Srl
  • Farmaderbe
  • Sopharma Group
  • Orifarm Group A/S
  • Polpharma S
  • Zentiva
  • Stada Arzneimittel AG
  • Krka, d. d.
  • Aflofarm
  • Herbapol Lublin
  • Ropharma
  • Dacia Plant
  • Hofigal
  • Evalar
  • JSC Pharmstandard
  • Jamieson Wellness Inc.
  • Natural Factors
  • Organika Health Products Inc.
  • Genomma Lab Internacional
  • Laboratorios Liomont
  • Medix
  • Pfizer Inc.
  • Johnson & Johnson
  • GSK Consumer Healthcare
  • Church & Dwight Co., Inc.
  • Elea Phoenix
  • Laboratorio Elea
  • Hypera Pharma
  • Laboratorios La Santé
  • Laboratorios Saval
  • Laboratorio Chile
  • Laboratorio Knop
  • Laboratorio Franco Colombiano Lafrancol
  • Corporación Infarmasa
  • Medifarma
  • Citrosuco
  • Darou Pakhsh Pharmaceutical Manufacturing Co.
  • Teva Pharmaceutical Industries Ltd.
  • Tabuk Pharmaceuticals Manufacturing Company
  • Abdi Ibrahim Pharmaceuticals
  • Caspian Tamin Pharmaceutical Company
  • Exir Pharmaceutical Company
  • Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO)
  • Jamjoom Pharmaceuticals
  • Zahravi Pharmaceutical Company
  • Alhavi Pharmaceutical Company
  • Dexxon Pharmaceutical Active Ingredients

      • Table Of Contents

      1 Executive Summary

      1.1 OTC Drug And Dietary Supplement – Market Attractiveness And Macro economic Landscape

      2 Table Of Contents

      3 List Of Tables

      4 List Of Figures

      5 Report Structure

      6 Market Characteristics

      6.1 General Market Definition

      6.2 Summary

      6.3 OTC Drug And Dietary Supplement Market Definition And Segmentations

      6.4 Market Segmentation By Category

      6.4.1 Vitamin And Dietary Supplements

      6.4.2 Cough And Cold Products

      6.4.3 Analgesics

      6.4.4 Gastrointestinal Products

      6.4.5 Skin

      6.4.6 Other Categories

      6.5 Market Segmentation By Dosage Form

      6.5.1 Tablets

      6.5.2 Hard Capsules

      6.5.3 Powders

      6.5.4 Ointments

      6.5.5 Soft Capsules

      6.5.6 Liquids

      6.5.7 Other Dosage Forms

      6.6 Market Segmentation By Distribution Channel

      6.6.1 Pharmacies

      6.6.2 Grocery Stores

      6.6.3 Vitamin And Health Food Stores

      6.6.4 Online Pharmacies

      7 Major Market Trends

      7.1 Expansion Of Production Capabilities In Dietary Supplements And OTC Drugs

      7.2 New Over-The-Counter Option For Opioid Overdose Reversal

      7.3 Launch Of Natural Herb-Based Supplement For Nursing Mothers

      7.4 Introduction Of OTC Drug Line For Pain And Allergy Relief

      7.5 Innovation In Women's Health Pharmaceuticals

      8 OTC Drug And Dietary Supplement Market – Macro-Economic Scenario

      8.1 COVID-19 Impact On The OTC Drug And Dietary Supplement Market

      8.2 Impact Of The War In Ukraine On The OTC Drug And Dietary Supplement Market

      8.3 Impact Of High Inflation On The OTC Drug And Dietary Supplement Market

      9 Global Market Size And Growth

      9.1 Market Size

      9.2 Historic Market Growth, 2018 – 2023, Value ($ Million)

      9.2.1 Market Drivers 2018 – 2023

      9.2.2 Market Restraints 2018 – 2023

      9.3 Forecast Market Growth, 2023 – 2028, 2033F Value ($ Million)

      9.3.1 Market Drivers 2023 – 2028

      9.3.2 Market Restraints 2023 – 2028

      10 Global OTC Drug And Dietary Supplement Market Segmentation

      10.1 Global OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      10.2 Global OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      10.3 Global OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      11 OTC Drug And Dietary Supplement Market, Regional and Country Analysis

      11.1 Global OTC Drug And Dietary Supplement Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      11.2 Global OTC Drug And Dietary Supplement Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12 Asia-Pacific Market

      12.1 Summary

      12.1.1 Market Overview

      12.1.2 Region Information

      12.1.3 Market Information

      12.1.4 Background Information

      12.1.5 Government Initiatives

      12.1.6 Regulations

      12.1.7 Regulatory Bodies

      12.1.8 Major Associations

      12.1.9 Taxes Levied

      12.1.10 Corporate Tax Structure

      12.1.11 Investments

      12.1.12 Major Companies

      12.2 Asia-Pacific OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.3 Asia-Pacific OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.4 Asia-Pacific OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.5 Asia-Pacific OTC Drug And Dietary Supplement Market: Country Analysis

      12.6 China Market

      12.7 Summary

      12.7.1 Market Overview

      12.7.2 Country Information

      12.7.3 Market Information

      12.7.4 Background Information

      12.7.5 Government Initiatives

      12.7.6 Regulations

      12.7.7 Regulatory Bodies

      12.7.8 Major Associations

      12.7.9 Taxes Levied

      12.7.10 Corporate Tax Structure

      12.7.11 Investments

      12.7.12 Major Companies

      12.8 China OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.9 China OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.10 China OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.11 India Market

      12.12 India OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.13 India OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.14 India OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.15 Japan Market

      12.16 Japan OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.17 Japan OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.18 Japan OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.19 Australia Market

      12.20 Australia OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.21 Australia OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.22 Australia OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.23 Indonesia Market

      12.24 Indonesia OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.25 Indonesia OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.26 Indonesia OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.27 South Korea Market

      12.28 South Korea OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.29 South Korea OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.30 South Korea OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13 Western Europe Market

      13.1 Summary

      13.1.1 Market Overview

      13.1.2 Region Information

      13.1.3 Market Information

      13.1.4 Background Information

      13.1.5 Government Initiatives

      13.1.6 Regulations

      13.1.7 Regulatory Bodies

      13.1.8 Major Associations

      13.1.9 Taxes Levied

      13.1.10 Corporate tax structure

      13.1.11 Investments

      13.1.12 Major Companies

      13.2 Western Europe OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.3 Western Europe OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.4 Western Europe OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.5 Western Europe OTC Drug And Dietary Supplement Market: Country Analysis

      13.6 UK Market

      13.7 UK OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.8 UK OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.9 UK OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.10 Germany Market

      13.11 Germany OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.12 Germany OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.13 Germany OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.14 France Market

      13.15 France OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.16 France OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.17 France OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.18 Italy Market

      13.19 Italy OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.20 Italy OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.21 Italy OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.22 Spain Market

      13.23 Spain OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.24 Spain OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.25 Spain OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14 Eastern Europe Market

      14.1 Summary

      14.1.1 Market Overview

      14.1.2 Region Information

      14.1.3 Market Information

      14.1.4 Background Information

      14.1.5 Government Initiatives

      14.1.6 Regulations

      14.1.7 Regulatory Bodies

      14.1.8 Major Associations

      14.1.9 Taxes Levied

      14.1.10 Corporate Tax Structure

      14.1.11 Investments

      14.1.12 Major Companies

      14.2 Eastern Europe OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.3 Eastern Europe OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.4 Eastern Europe OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.5 Eastern Europe OTC drug And Dietary Supplement Market: Country Analysis

      14.6 Russia Market

      14.7 Russia OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.8 Russia OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.9 Russia OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15 North America Market

      15.1 Summary

      15.1.1 Market Overview

      15.1.2 Region Information

      15.1.3 Market Information

      15.1.4 Background Information

      15.1.5 Government Initiatives

      15.1.6 Regulations

      15.1.7 Regulatory Bodies

      15.1.8 Major Associations

      15.1.9 Taxes Levied

      15.1.10 Corporate Tax Structure

      15.1.11 Investments

      15.1.12 Major Companies

      15.2 North America OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.3 North America OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.4 North America OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.5 North America OTC Drug And Dietary Supplement Market: Country Analysis

      15.6 USA Market

      15.7 Summary

      15.7.1 Market Overview

      15.7.2 Country Information

      15.7.3 Market Information

      15.7.4 Background Information

      15.7.5 Government Initiatives

      15.7.6 Regulations

      15.7.7 Regulatory Bodies

      15.7.8 Major Associations

      15.7.9 Taxes Levied

      15.7.10 Corporate Tax Structure

      15.7.11 Investments

      15.7.12 Major Companies

      15.8 USA OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.9 USA OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.10 USA OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.11 Canada Market

      15.12 Canada OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.13 Canada OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.14 Canada OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16 South America Market

      16.1 Summary

      16.1.1 Market Overview

      16.1.2 Region Information

      16.1.3 Market Information

      16.1.4 Background Information

      16.1.5 Government Initiatives

      16.1.6 Regulations

      16.1.7 Regulatory Bodies

      16.1.8 Major Associations

      16.1.9 Taxes Levied

      16.1.10 Corporate Tax Structure

      16.1.11 Investments

      16.1.12 Major Companies

      16.2 South America OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.3 South America OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.4 South America OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.5 South America OTC Drug And Dietary Supplement Market: Country Analysis

      16.6 Brazil Market

      16.7 Brazil OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.8 Brazil OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.9 Brazil OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      17 Middle East Market

      17.1 Summary

      17.1.1 Market Overview

      17.1.2 Region Information

      17.1.3 Market Information

      17.1.4 Background Information

      17.1.5 Government Initiatives

      17.1.6 Regulations

      17.1.7 Regulatory Bodies

      17.1.8 Major Associations

      17.1.9 Taxes Levied

      17.1.10 Corporate Tax Structure

      17.1.11 Investments

      17.1.12 Major Companies

      17.2 Middle East OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      17.3 Middle East OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      17.4 Middle East OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      18 Africa Market

      18.1 Summary

      18.1.1 Market Overview

      18.1.2 Region Information

      18.1.3 Market Information

      18.1.4 Background Information

      18.1.5 Government Initiatives

      18.1.6 Regulations

      18.1.7 Regulatory Bodies

      18.1.8 Major Associations

      18.1.9 Taxes Levied

      18.1.10 Corporate Tax Structure

      18.1.11 Investments

      18.1.12 Major Companies

      18.2 Africa OTC drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      18.3 Africa OTC drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      18.4 Africa OTC drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      19 Competitive Landscape And Company Profiles

      19.1 Company Profiles

      19.2 Nestle S.A.

      19.2.1 Company Overview

      19.2.2 Products And Services

      19.2.3 Business Strategy

      19.2.4 Financial Overview

      19.3 The Procter & Gamble Company

      19.3.1 Company Overview

      19.3.2 Products And Services

      19.3.3 Financial Overview

      19.4 Haleon plc

      19.4.1 Company Overview

      19.4.2 Products And Services

      19.4.3 Business Strategy

      19.4.4 Financial Overview

      19.5 Abbott Laboratories

      19.5.1 Company Overview

      19.5.2 Products And Services

      19.5.3 Business Strategy

      19.5.4 Financial Overview

      19.6 Sanofi S.A

      19.6.1 Company Overview

      19.6.2 Products And Services

      19.6.3 Business Strategy

      19.6.4 Financial Overview

      20 Other Major And Innovative Companies

      20.1 Reckitt Benckiser Group plc

      20.1.1 Company Overview

      20.1.2 Products And Services

      20.2 Bayer AG

      20.2.1 Company Overview

      20.2.2 Products And Services

      20.3 Church & Dwight Co. Inc

      20.3.1 Company Overview

      20.3.2 Products And Services

      20.4 Nature's Bounty Co

      20.4.1 Company Overview

      20.4.2 Products And Services

      20.5 Perrigo Company plc

      20.5.1 Company Overview

      20.5.2 Products And Services

      20.6 GNC Holdings Inc.

      20.6.1 Company Overview

      20.6.2 Products And Services

      20.7 Sun Pharmaceutical Industries Ltd

      20.7.1 Company Overview

      20.7.2 Products And Services

      20.8 Novartis AG

      20.8.1 Company Overview

      20.8.2 Products And Services

      20.9 Pfizer Inc

      20.9.1 Company Overview

      20.9.2 Products And Services

      20.10 Merck & Co. Inc

      20.10.1 Company Overview

      20.10.2 Products And Services

      20.11 Pharmavite LLC

      20.11.1 Company Overview

      20.11.2 Products And Services

      20.12 Hain Celestial Group Inc

      20.12.1 Company Overview

      20.12.2 Products And Services

      20.13 Blackmores Limited

      20.13.1 Company Overview

      20.13.2 Products And Services

      20.14 Cipla Inc

      20.14.1 Company Overview

      20.14.2 Products And Services

      20.15 Amway

      20.15.1 Company Overview

      20.15.2 Products And Services

      21 Competitive Benchmarking

      22 Competitive Dashboard

      23 Key Mergers And Acquisitions

      23.1 Dr. Reddy's Laboratories Acquired MenoLabs

      23.2 Dexcel Pharma Acquired Teva Pharmaceutical Industries Ltd

      23.3 Cipla Limited Acquired Actor Pharma

      23.4 SGS S.A. Acquired Nutrasource Pharmaceutical and Nutraceutical Services Inc.

      23.5 The Kirin Holdings Company Limited Acquired Blackmores Limited

      23.6 Balchem Corporation Acquired Bergstrom Nutrition

      23.7 Glenmark Pharmaceuticals Ltd Acquired Wockhardt Ltd

      23.8 Acino Acquired Aspen Pharmacare Holdings Limited

      23.9 Douglas Acquired Disapo

      23.10 Merieux NutriSciences Acquired Dyad Labs

      23.11 Laboratorios Rubió Acquired Fisiopharma S.r.l.

      23.12 Fidia Farmaceutici Acquired Sanofi

      24 Opportunities And Strategies

      24.1 Global OTC Drug And Dietary Supplement Market In 2028 – Countries Offering Most New Opportunities

      24.2 Global OTC Drug And Dietary Supplement Market In 2028 – Segments Offering Most New Opportunities

      24.3 Global OTC Drug And Dietary Supplement Market In 2028 – Growth Strategies

      24.3.1 Market Trend Based Strategies

      24.3.2 Competitor Strategies

      25 OTC Drug And Dietary Supplement Market, Conclusions And Recommendations

      25.1 Conclusions

      25.2 Recommendations

      25.2.1 Product

      25.2.2 Place

      25.2.3 Price

      25.2.4 Promotion

      25.2.5 People

      26 Appendix

      26.1 Geographies Covered

      26.2 Market Data Sources

      26.3 Research Methodology

      26.4 Currencies

      26.5 The Business Research Company

      26.6 Copyright and Disclaimer

    List Of Tables

      Table 1: Global OTC Drug And Dietary Supplement Market, Historic, 2018 – 2023, $ Million
    • Table 2: Global OTC Drug And Dietary Supplement Market, Forecast, 2023 – 2028, 2033F, $ Million
    • Table 3: Global OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 4: Global OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 5: Global OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 6: Global OTC Drug And Dietary Supplement Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 7: Global OTC Drug And Dietary Supplement Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 8: Asia-Pacific GDP Per Capita, By Country, 2018-2023, $
    • Table 9:  Asia-Pacific Population, By Country, 2018-2028, Millions
    • Table 10: Asia-Pacific OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 11: Asia-Pacific OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 12: Asia-Pacific OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 13: China GDP Per Capita, 2018-2023, $
    • Table 14:  China Population, 2018-2028, Millions
    • Table 15: China OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 16: China OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 17: China OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 18: India OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 19: India OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 20: India OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 21: Japan OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 22: Japan OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 23: Japan OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 24: Australia OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 25: Australia OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 26: Australia OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 27: Indonesia OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 28: Indonesia OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 29: Indonesia OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 30: South Korea OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 31: South Korea OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 32: South Korea OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 33: Western Europe GDP Per Capita, By Country, 2018-2023, $
    • Table 34:  Western Europe Population, By Country, 2018-2028, Millions
    • Table 35: Western Europe OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 36: Western Europe OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 37: Western Europe OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 38: UK OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 39: UK OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 40: UK OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 41: Germany OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 42: Germany OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 43: Germany OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 44: France OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 45: France OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 46: France OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 47: Italy OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 48: Italy OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 49: Italy OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 50: Spain OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 51: Spain OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 52: Spain OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 53: Eastern Europe GDP Per Capita, By Country, 2018-2023, $
    • Table 54:  Eastern Europe Population, By Country, 2018-2028, Millions
    • Table 55: Eastern Europe OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 56: Eastern Europe OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 57: Eastern Europe OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 58: Russia OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 59: Russia OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 60: Russia OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 61: North America GDP Per Capita, By Country, 2018-2023, $
    • Table 62:  North America Population, By Country, 2018-2028, Millions
    • Table 63: North America OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 64: North America OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 65: North America OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 66: USA GDP Per Capita, 2018-2023, $
    • Table 67:  USA Population, 2018-2028, Millions
    • Table 68: USA OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 69: USA OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 70: USA OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 71: Canada OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 72: Canada OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 73: Canada OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 74: South America GDP Per Capita, By Country, 2018-2023, $
    • Table 75:  South America Population, By Country, 2018-2028, Millions
    • Table 76: South America OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 77: South America OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 78: South America OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 79: Brazil OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 80: Brazil OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 81: Brazil OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 82: Middle East GDP Per Capita, By Country, 2018-2023, $
    • Table 83:  Middle East Population, By Country, 2018-2028, Millions
    • Table 84: Middle East OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 85: Middle East OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 86: Middle East OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 87: Africa GDP Per Capita, By Country, 2018-2023, $
    • Table 88:  Africa Population, By Country, 2018-2028, Millions
    • Table 89: Africa OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 90: Africa OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 91: Africa OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 92: Global OTC Drug And Dietary Supplement Market, Key Competitor Estimated Market Shares, 2023, Percentage (%)
    • Table 93: Nestle S.A – Financial Overview, 2019 – 2023, $ Billion
    • Table 94: The Procter & Gamble Company – Financial Overview, 2019 – 2023, $Billion
    • Table 95: Haleon plc – Financial Overview, 2021 – 2023, $ Billion
    • Table 96: Abbott Laboratories – Financial Overview, 2019 – 2023, $Billion
    • Table 97: Sanofi S.A – Financial Overview, 2019 – 2023, $Billion
    • Table 98: OTC Drug And Dietary Supplement Market, Competitive Benchmarking (In USD Millions)
    • Table 99: OTC Drug And Dietary Supplement Market, Competitive Dashboard
    • Table 100: Global OTC Drug And Dietary Supplement Market Size Gain ($ Million), 2023 – 2028, By Country
    • Table 101: Global OTC Drug And Dietary Supplement Market Size Gain ($ Million), Segmentation By Category, 2023 – 2028
    • Table 102: Global OTC Drug And Dietary Supplement Market Size Gain ($ Million), Segmentation By Dosage Form, 2023 – 2028
    • Table 103: Global OTC Drug And Dietary Supplement Market Size Gain ($ Million), Segmentation By Distribution Channel, 2023 – 2028
    • Table 104: OTC Drug And Dietary Supplement Market Data Sources

    List Of Figures

      Figure 1: Global OTC Drug And Dietary Supplement Market Segmentation By Category
    • Figure 2: Global OTC Drug And Dietary Supplement Market Segmentation By Dosage Form
    • Figure 3: Global OTC Drug And Dietary Supplement Market Segmentation By Distribution Channel
    • Figure 4: Global OTC Drug And Dietary Supplement Market, Historic, 2018 – 2023, $ Million
    • Figure 5: Global OTC Drug And Dietary Supplement Market, Forecast, 2023 – 2028, 2033F, $ Million
    • Figure 6: Global OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 7: Global OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 8: Global OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 9: Global OTC Drug And Dietary Supplement Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 10: Global OTC Drug And Dietary Supplement Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 11: Asia-Pacific OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 12: Asia-Pacific OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 13: Asia-Pacific OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 14: China OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 15: China OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 16: China OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 17: India OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 18: India OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 19: India OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 20: Japan OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 21: Japan OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 22: Japan OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 23: Australia OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 24: Australia OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 25: Australia OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 26: Indonesia OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 27: Indonesia OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 28: Indonesia OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 29: South Korea OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 30: South Korea OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 31: South Korea OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 32: Western Europe OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 33: Western Europe OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 34: Western Europe OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 35: UK OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 36: UK OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 37: UK OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 38: Germany OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 39: Germany OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 40: Germany OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 41: France OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 42: France OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 43: France OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 44: Italy OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 45: Italy OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 46: Italy OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 47: Spain OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 48: Spain OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 49: Spain OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 50: Eastern Europe OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 51: Eastern Europe OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 52: Eastern Europe OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 53: Russia OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 54: Russia OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 55: Russia OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 56: North America OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 57: North America OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 58: North America OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 59: USA OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 60: USA OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 61: USA OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 62: Canada OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 63: Canada OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 64: Canada OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 65: South America OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 66: South America OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 67: South America OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 68: Brazil OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 69: Brazil OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 70: Brazil OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 71: Middle East OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 72: Middle East OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 73: Middle East OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 74: Africa OTC Drug And Dietary Supplement Market, Segmentation By Category, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 75: Africa OTC Drug And Dietary Supplement Market, Segmentation By Dosage Form, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 76: Africa OTC Drug And Dietary Supplement Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 77: Global OTC Drug And Dietary Supplement, Key Competitor Estimated Market Shares, 2023, Percentage (%)
    • Figure 78: Nestle S.A – Financial Overview, 2019 – 2023, $ Billion
    • Figure 79: The Procter & Gamble Company – Financial Overview, 2019 – 2023, $ Billion
    • Figure 80: Haleon plc – Financial Overview, 2021 – 2023, $ Billion
    • Figure 81: Abbott Laboratories – Financial Overview, 2019 – 2023, $ Billion
    • Figure 82: Sanofi S.A – Financial Overview, 2019 – 2023, $ Billion
    • Figure 83: Geographic Regions Covered

    The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

    Read More

    Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

    Read More

    Global Gene Therapy Market 2022 – Market Opportunities And Strategies

    Read More

    The Microbiome Market Share, Market Size, And Growth Rate 2022

    Read More

    Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company

    Read More

    The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the biosimilars market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the high potency apis market research report 2022 with industry size, share, segments and market growth

    Read More

    CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By Region, Opportunities And Strategies – Global Forecast To 2030

    View Report

    Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Intravenous, Intranasal/ Inhalation), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Over-The-Counter Drugs, Prescription-Based Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030

    View Report

    Protein Inhibitors Global Market Report 2024 – By Product (Protein Kinase Inhibitors, Monoclonal Antibody, Other Products), By Application (Oncology, Inflammatory Diseases, Other Applications), By Distribution Channel (Hospital Pharmacies, Independent Pharmacies, Online Pharmacies ) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Enzymes Global Market Report 2024 – By Product Type (Asparaginase, Lipase, Protease, Nattokinase, Chitinase, Serratiopeptidase, Collagenase, Ligase, Other Products), By Application (Leukemia, Stomach Disorders, Antitumor, Skin Ulcers, Gaucher Disease, Fabry Disease, Other Applications), By End User (Drug Manufacturers, Hospitals, Private Clinics, Research Laboratories) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Digestive Enzymes Global Market Report 2024 – By Enzyme Type (Carbohydrates, Protease, Lipase, Other Enzyme Types), By Origin (Animal, Fungi, Microbial, Plant), By Application (Indigestion, Chronic Pancreatitis, Irritable Bowel Syndrome, Other Applications), By Distribution Channel (Retail Stores, Online Stores) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Oncology Biosimilars Global Market Report 2024 – By Drug Type (Monoclonal Antibody, Immunomodulators, Hematopoietic Agents, Granulocyte Colony-Stimulating Factor (G-CSF)), By Cancer Type (Breast Cancer, Colorectal Cancer, Blood Cancer, Neutropenia Cancer, Non-Small Cell Lung Cancer, Other Cancer Types), By Distribution Type (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Corticosteroids Global Market Report 2024 – By Product (Glucocorticoids, Mineralocorticoids), By Application (Skin Allergies, Rheumatology Indications, Endocrinology, Acute Respiratory Diseases, Other Applications), By End User (Hospitals, Clinics, Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Interferons Global Market Report 2024 – By Type (Interferon Alpha, Interferon Beta, Interferon Gamma), By Application (Hepatitis B, Hepatitis C, Melanoma, Leukemia, Multiple Sclerosis, Renal Cell Carcinoma), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

    View Report